Dimed S.A. Distribuidora de Medicamentos (BVMF: PNVL3)

PNVL3 Income Statement

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	4,712	4,461	3,990	3,225	2,819	2,725
Revenue Growth (YoY)	11.88%	11.79%	23.72%	14.41%	3.47%	12.02%
Cost of Revenue	3,230	3,079	2,745	2,231	1,988	1,908
Gross Profit	1,482	1,382	1,245	994.64	831.01	816.65
Selling, General & Admin	1,306	1,210	1,099	907.41	726.33	687.29
Other Operating Expenses	16.15	9.53	8	-15.56	11.29	10.5
Operating Expenses	1,322	1,220	1,107	891.85	737.62	697.79
Operating Income	159.93	161.89	137.84	102.78	93.39	118.86
Interest Expense	-105.77	-102.57	-70.03	-37.12	-35.31	-34.98
Interest & Investment Income	37.5	34.39	18.18	16.63	6.05	2.91
Other Non Operating Income (Expenses)	-8.21	-6.81	-7.01	2.2	-9.6	-6.78
EBT Excluding Unusual Items	83.45	86.9	78.99	84.49	54.54	80.02
Gain (Loss) on Sale of Assets	-4.73	-2.26	-2.07	-2.74	-1.85	-
Other Unusual Items	6.9	6.95	1.51	1.49	0.62	0.82
Pretax Income	85.61	91.58	78.43	83.24	53.3	80.84
Income Tax Expense	-5.73	-1.32	-7.92	3.81	-2.85	4.09
Net Income	91.34	92.91	86.35	79.43	56.15	76.76
Net Income to Common	91.34	92.91	86.35	79.43	56.15	76.76
Net Income Growth	10.55%	7.60%	8.71%	41.45%	-26.84%	2.36%
Shares Outstanding (Basic)	149	149	149	150	151	135
Shares Outstanding (Diluted)	149	149	149	150	152	135
Shares Change (YoY)	-0.79%	0.09%	-0.68%	-1.27%	11.84%	-0.55%
EPS (Basic)	0.61	0.62	0.58	0.53	0.37	0.57
EPS (Diluted)	0.61	0.62	0.58	0.53	0.37	0.57
EPS Growth	10.85%	6.90%	9.43%	43.02%	-34.59%	2.93%
Free Cash Flow	219.99	182.2	56.18	21.13	67.1	89.27
Free Cash Flow Per Share	1.48	1.23	0.38	0.14	0.44	0.66
Dividend Per Share	0.198	0.252	-	0.175	0.136	0.168
Dividend Growth	-	-	-	28.37%	-19.11%	15.29%
Gross Margin	31.45%	30.97%	31.20%	30.84%	29.48%	29.97%
Operating Margin	3.39%	3.63%	3.45%	3.19%	3.31%	4.36%
Profit Margin	1.94%	2.08%	2.16%	2.46%	1.99%	2.82%
Free Cash Flow Margin	4.67%	4.08%	1.41%	0.66%	2.38%	3.28%
EBITDA	139.29	212.49	322.41	260.56	211.17	214.2
EBITDA Margin	2.96%	4.76%	8.08%	8.08%	7.49%	7.86%
D&A For EBITDA	-20.64	50.61	184.57	157.77	117.78	95.34
EBIT	159.93	161.89	137.84	102.78	93.39	118.86
EBIT Margin	3.39%	3.63%	3.45%	3.19%	3.31%	4.36%
Effective Tax Rate	-	-	-	4.58%	-	5.05%
Revenue as Reported	4,712	4,461	3,990	3,225	-	-
Advertising Expenses	-	29.34	26.21	19.88	17.54	19.32

Source: S&P Capital IQ. Standard template. Financial Sources.